Cargando…

Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study

BACKGROUND: The association between cutaneous melanoma and subsequent risk of prostate cancer (PC) was examined in a large population-based cohort study. METHODS: Male participants in the Sax Institute’s 45 and Up Study (Australia) were recruited between 2006 and 2009. Questionnaire data and linked...

Descripción completa

Detalles Bibliográficos
Autores principales:	Egger, Sam, Smith, David P., Patel, Manish I., Kimlin, Michael G., Armstrong, Bruce K., Nair-Shalliker, Visalini
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814593/ https://www.ncbi.nlm.nih.gov/pubmed/36319848 http://dx.doi.org/10.1038/s41416-022-02027-7

Ejemplares similares

Physical activity, obesity and sedentary behaviour and the risks of colon and rectal cancers in the 45 and up study
por: Nunez, Carlos, et al.
Publicado: (2018)

Factors associated with prostate specific antigen testing in Australians: Analysis of the New South Wales 45 and Up Study
por: Nair-Shalliker, Visalini, et al.
Publicado: (2018)

Post-treatment levels of plasma 25- and 1,25-dihydroxy vitamin D and mortality in men with aggressive prostate cancer
por: Nair-Shalliker, Visalini, et al.
Publicado: (2020)

Associations between sun sensitive pigmentary genes and serum prostate specific antigen levels
por: Nair-Shalliker, Visalini, et al.
Publicado: (2018)

Family history, obesity, urological factors and diabetic medications and their associations with risk of prostate cancer diagnosis in a large prospective study
por: Nair-Shalliker, Visalini, et al.
Publicado: (2022)

High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): protocol of a phase II randomised controlled trial
por: Nair-Shalliker, Visalini, et al.
Publicado: (2021)

An initial melanoma diagnosis may increase the subsequent risk of prostate cancer: Results from the New South Wales Cancer Registry
por: Cole-Clark, D., et al.
Publicado: (2018)

Large-scale systematic analysis of exposure to multiple cancer risk factors and the associations between exposure patterns and cancer incidence
por: Steinberg, Julia, et al.
Publicado: (2021)

Low-Value Prostate-Specific Antigen Test for Prostate Cancer Screening and Subsequent Health Care Utilization and Spending
por: Kim, David D., et al.
Publicado: (2022)

Skin Melanoma and Subsequent Risk of Prostate Cancer: A Lithuanian Cancer Registry Study
por: Patasius, Ausvydas, et al.
Publicado: (2019)

Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study
por: Mazariego, Carolyn G, et al.
Publicado: (2020)

Updates of prostate cancer staging: Prostate-specific membrane antigen
por: Sathianathen, Niranjan J, et al.
Publicado: (2016)

Gene‒Prostate-Specific-Antigen-Guided Personalized Screening for Prostate Cancer
por: Yang, Teng-Kai, et al.
Publicado: (2019)

Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in scotland.
por: MacKie, R. M., et al.
Publicado: (1982)

Impact of Treatment With Statins on Prostate-Specific Antigen and Prostate Volume in Patients With Benign Prostatic Hyperplasia
por: Lee, Sang Hun, et al.
Publicado: (2013)

Cutaneous metastases of prostatic adenocarcinoma
por: Patne, Shashikant C.U., et al.
Publicado: (2015)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
por: Ben Jemaa , Awatef, et al.
Publicado: (2010)

Recurrence of Prostate Cancer with Cutaneous Metastasis after Radical Prostatectomy
por: Patel, Parth, et al.
Publicado: (2015)

Prostate specific antigen /
Publicado: (2001)

Association of Diet With Prostate Specific Antigen and Prostate Volume
por: Shirazi, Mehdi, et al.
Publicado: (2014)

Cutaneous metastasis from prostate carcinoma
por: Gupta, Savera, et al.
Publicado: (2017)

UVB-Stimulated TNFα Release from Human Melanocyte and Melanoma Cells Is Mediated by p38 MAPK
por: Muthusamy, Visalini, et al.
Publicado: (2013)

Primary malignant melanoma of prostate
por: Doublali, M., et al.
Publicado: (2010)

Prostate Metastasis of Malignant Melanoma
por: Balaban, Muhsin, et al.
Publicado: (2013)

An Unusual Prostate-Specific Antigen Decrease in an Advanced Castration-Resistant Prostate Cancer Patient with Intracerebral Hemorrhage Subsequently Treated with Luteinizing Hormone-Releasing Hormone Antagonist
por: Izumi, Kouji, et al.
Publicado: (2013)

Benign prostatic hyperplasia and subsequent risk of bladder cancer
por: Kang, D, et al.
Publicado: (2007)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
por: Shahab, Ahmad Anies, et al.
Publicado: (2013)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
por: Teoh, Jeremy YC, et al.
Publicado: (2017)

Prostate-Specific Antigen Mass and Free Prostate-Specific Antigen Mass for Predicting the Prostate Volume of Korean Men With Biopsy-Proven Benign Prostatic Hyperplasia
por: Park, Tae Yong, et al.
Publicado: (2013)

Quality of life three years after diagnosis of localised prostate cancer: population based cohort study
por: Smith, David P, et al.
Publicado: (2009)

Prostate ultrasound—for urologists only?: Tuesday 4 October 2005, 08:45–10:45
por: Frauscher, Ferdinand, et al.
Publicado: (2005)

Advice About Screening for Prostate Cancer With Prostate-Specific Antigen
por: Jean-Pierre, Gannel
Publicado: (2017)

Re: Prognosis of prostate cancer and prostate - specific antigen levels
por: Joob, Beuy, et al.
Publicado: (2019)

Prostate-specific membrane antigen-mediated theragnostics in prostate cancer
por: Jeong, Seung-hwan, et al.
Publicado: (2021)

The Specific Choice of Transrectal Ultrasound-Guided Prostate Biopsy Scheme Based on Prostate Specific Antigen and Prostate Specific Antigen Density
por: Chen, Yue, et al.
Publicado: (2019)

A Prospective Study of Reducing Unnecessary Prostate Biopsy in Patients with High Serum Prostate-Specific Antigen with Consideration of Prostatic Inflammation
por: Lee, An Gu, et al.
Publicado: (2012)

Up-Regulated Dicer Expression in Patients with Cutaneous Melanoma
por: Ma, Zhihai, et al.
Publicado: (2011)

Prostate-specific antigen testing in Tyrol, Austria: prostate cancer mortality reduction was supported by an update with mortality data up to 2008
por: Oberaigner, Willi, et al.
Publicado: (2011)

Prostate-specific antigen testing in Tyrol, Austria: prostate cancer mortality reduction was supported by an update with mortality data up to 2008
por: Schröder, Fritz H., et al.
Publicado: (2011)

The Prostate Cancer Detection Rate on the Second Prostate Biopsy according to Prostate-Specific Antigen Trend
por: Kim, Hyung-Sang, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_av9bvvie3ev1nskbg1htmr73b5